| OCGN Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the OCGN shares outstanding history going back to 9/30/2019:
Also see: OCGN Market Cap History OCGN YTD Return |
OCGN Shares Outstanding History — Ocugen Share Count Over Time
As of 4/30/2026 Ocugen has 338.52 million OCGN shares outstanding. Investors often track the OCGN shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows OCGN share count trends over time, with 28 historical shares outstanding datapoints presented, dating back to 9/30/2019.
| OCGN Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
OCGN Historical Shares Outstanding: +125.97% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| OCGN Stock Price Chart |
| About Ocugen Inc |
| Ocugen is a biopharmaceutical company focused on gene and cell therapies, biologics, and vaccines to improve global health. Its pipeline includes a modifier gene therapy platform, regenerative medicine cell therapy platform, and biologic therapies for retinal diseases. Ocugen is developing OCU400, OCU410, and OCU410ST for inherited retinal diseases like retinitis pigmentosa, Leber congenital amaurosis, Stargardt disease, and multifactorial diseases such as dry age-related macular degeneration and geographic atrophy. Co. is working on an inhalation-based mucosal vaccine platform with OCU500 (COVID-19 vaccine), OCU510 (seasonal flu vaccine), and OCU520 (combination flu and COVID-19 vaccine). We show 28 historical shares outstanding datapoints in our coverage of OCGN's shares outstanding history. Understanding the changing numbers of OCGN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like OCGN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching OCGN by allowing them to research OCGN shares outstanding history as well as any other stock in our coverage universe. |
| OCGN Current Stock Quote |
Quotes delayed 20 minutes  Free OCGN Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| OCGN Share Performance |
| Shares Outstanding Peers |
| Ocugen (OCGN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
OCUL Shares Outstanding History OCUP Shares Outstanding History OCX Shares Outstanding History ODT Shares Outstanding History ODYS Shares Outstanding History OFIX Shares Outstanding History OGN Shares Outstanding History OHRP Shares Outstanding History OKUR Shares Outstanding History OLMA Shares Outstanding History More Healthcare companies » |
OCGN Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
